Article Details
Retrieved on: 2025-03-27 18:09:02
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a significant investment in Maxion Therapeutics, a biotech firm focusing on antibody-based treatments targeting ion channels and GPCRs. This aligns with the core concepts of 'Biotechnology' and tags such as 'Ion channel', 'G protein-coupled receptor', and 'Antibody'.
Article found on: www.biopharminternational.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here